Faculty Disclosures
| Owen T. Carmichael, PhD |
No disclosure on file
|
| Jennifer Whitwell, PhD |
Dr. Whitwell has nothing to disclose. |
| Charles S. DeCarli, MD, FAAN |
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
| John M. Ringman, MD, FAAN |
The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP. |
|
No disclosure on file
|
| Hilary W. Heuer |
No disclosure on file
|
| Kristy Hwang |
No disclosure on file
|
| Danielle Harvey, PA-C |
No disclosure on file
|
| Bruce R. Reed, PhD |
No disclosure on file
|
| Pauline Maillard, PhD |
No disclosure on file
|
| Bradley F. Boeve, MD, FAAN |
Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Dan M. Mungas, PhD |
Dr. Mungas has nothing to disclose. |
| Melissa Murray, PhD |
Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative. |
| Liana Apostolova, MD, FAAN |
Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. |
| Giovanni Coppola, MD |
Dr. Coppola has received personal compensation for serving as an employee of Regeneron. Dr. Coppola has received stock or an ownership interest from Regeneron. |
| David F. Tang-Wai, MD, FRCPC |
Dr. Tang-Wai has nothing to disclose. |
| Tiffany W. Chow, MD, FAAN |
Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA. |
| David S. Knopman, MD, FAAN |
Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Prashanthi Vemuri, PhD |
The institution of Dr. Vemuri has received research support from NIH. |
| Mohamad A. Mikati, MD |
No disclosure on file
|
| Belen Pascual, PhD |
The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH. |
| Lisa Silbert, MD, FAAN |
The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
| Joseph C. Masdeu, MD, PhD, FAAN |
Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |
| Constantine Lyketsos |
No disclosure on file
|
| Tanis J. Ferman, PhD |
Ms. Ferman has nothing to disclose. |
| Mario Masellis, MD |
Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care. |
| Jeffrey A. Kaye, MD, FAAN |
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
| Marilyn Albert |
Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health. |
| Paul M. Thompson, PhD |
No disclosure on file
|
| Dennis W. Dickson, MD |
Dr. Dickson has nothing to disclose. |
| Clifford R. Jack, Jr., MD |
The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
| Matthew Senjem |
Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic. |
| Stephen Weigand |
Stephen Weigand has nothing to disclose. |
| Hiroko H. Dodge, PhD |
No disclosure on file
|
| Kejal Kantarci, MD |
The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. |
| Ronald C. Petersen, MD, PhD, FAAN |
Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Kenichi Oishi, MD, PhD |
No disclosure on file
|
| Joseph E. Parisi, MD |
Dr. Parisi has nothing to disclose. |
| Glenn E. Smith, MD, PhD |
No disclosure on file
|
| Michelle Mielke |
No disclosure on file
|
| Norman A. Farb, PhD |
No disclosure on file
|
| Rahul H. Dave, MD, PhD |
No disclosure on file
|
| Shubir Dutt |
Mr. Dutt has nothing to disclose. |
| Behrang Saminejad, MD |
No disclosure on file
|
| Sujay M. Kansagra, MD |
No disclosure on file
|
| Alex Hillyer |
No disclosure on file
|
| Lilly Fagatele |
Ms. fagatele has nothing to disclose. |